BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

Bearish flow noted in AstraZeneca (AZN) with 57,094 puts trading, or 10x expected. Most active are Nov-24 75 puts and Nov-24 70 puts, with total volume in those strikes near 33,200 contracts. The ...

The FTSE 100 and European stocks opened lower on Friday morning in London as chancellor Rachel Reeves said she is "not ...

AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Jitters over the health of the UK economy have been fuelled by today’s weaker-than-expected GDP release. September’s 0.1% ...

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

All 11 sectors are in the green for the year. The optimism comes as the economy is likely to continue to grow because the ...

London stocks fell in early trade on Friday as data showed that economic growth in the UK unexpectedly slowed in the third ...

Investing.com-- Most Asian currencies moved little on Friday and were nursing losses for the week, while the dollar steadied ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai ...